117 related articles for article (PubMed ID: 3841599)
1. [Antifibrillatory and anti-arrhythmic action of 3-carbethoxyamino-5-dimethylamino-acetyl iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on models of myocardial ischemia].
Kaverina NV; Lyskovzev VV; Grigoreva JK; Senova ZP; Sulakvelidze MT; Grizenko AN
Pharmazie; 1985 Dec; 40(12):845-7. PubMed ID: 3841599
[TBL] [Abstract][Full Text] [Related]
2. [Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat].
Poppe H; Femmer K; Kaverina NV; Lyskovzev VV; Grigoreva JK; Mazievskij DD
Pharmazie; 1985 Dec; 40(12):857-61. PubMed ID: 3841603
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog].
Kaverina NV; Rodionov AP; Lyskovzev VV; Grigoreva JK; Sulakvelidze MT; Poppe H; Klemm W; Morgenroth U
Pharmazie; 1985 Dec; 40(12):869-70. PubMed ID: 3841607
[TBL] [Abstract][Full Text] [Related]
4. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride].
Femmer K; Poppe H; Heer S; Bartsch R
Pharmazie; 1985 Dec; 40(12):836-40. PubMed ID: 3841597
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of the anti-arrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-imino-dibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015)].
Kaverina NV; Berdjajev SJ; Darinskij NV
Pharmazie; 1985 Dec; 40(12):840-4. PubMed ID: 3841598
[TBL] [Abstract][Full Text] [Related]
6. [Antiarrhythmic effectiveness of 3-carbalkoxyamino-5-(omega-aminoacyl)-10,11-dihydro-5H-dibenz-[b,f]- azepines].
Kaverina NV; Senova ZP; Lyskovzev VV; Demina LM; Grizenko AN; Skoldinov AP; Femmer K; Poppe H; Stark A; Wunderlich H
Pharmazie; 1985 Dec; 40(12):830-2. PubMed ID: 4095141
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the cat].
Kaverina NV; Rodionov AP; Berdjajev SJ; Darinskij NW; Sulakvelidze MT; Klemm W
Pharmazie; 1985 Dec; 40(12):868-9. PubMed ID: 3841606
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacologic studies on the effect of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on the vegetative and central nervous system].
Rostock A; Hoffmann W; Ploen U; Bartsch R
Pharmazie; 1985 Dec; 40(12):875-8. PubMed ID: 3841610
[TBL] [Abstract][Full Text] [Related]
9. [Clinico-electrophysiologic studies on the action of the anti-arrhythmic substance 3-carbethoxyamino-5-dimethylamino-acetyl-10,11-dihydro-5H- dibenz[b,f]azepine hydrochloride (Bonnecor, AWD 19-166, GS 015)].
Rostock KJ; Rathgen K; Pfeiffer D; Rostock G
Pharmazie; 1985 Dec; 40(12):862-4. PubMed ID: 3841604
[TBL] [Abstract][Full Text] [Related]
10. [Bonnecor--a new anti-arrhythmia preparation].
Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of a new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015) on mammalian myocardium.
Nilius B; Schüttler K; Benndorf K; Boldt W
Pharmazie; 1985 Dec; 40(12):847-51. PubMed ID: 3841600
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic vs. antifibrillatory activity of the basic diphenylhydantoin derivative 3-[3-(4-phenyl-1-piperidyl)propyl]-5-(4-methoxyphenyl)-5-phenylhydantoin hydrochloride.
Lynch J; Montgomery D; Ventura A; Wilber D; Lucchesi BR
Arzneimittelforschung; 1986 Mar; 36(3):475-81. PubMed ID: 3707667
[TBL] [Abstract][Full Text] [Related]
13. [Summarized presentation of studies on the toxicology of 3-carbethoxyamino-5-dimethylamino-acetyl-10,11- dihydrobenz[b,f]azepine hydrochloride (Bonnecor, GS 015, AWD 19-166)].
Nürnberger H; Stade K
Pharmazie; 1985 Dec; 40(12):871-3. PubMed ID: 3841608
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and metabolism of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the rat].
Klemm W; Morgenroth U; Joram U; Rodionov AP
Pharmazie; 1985 Dec; 40(12):864-7. PubMed ID: 3841605
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological research on bonnecor and its metabolites].
Poppe H; Heer S; Barch R
Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381
[TBL] [Abstract][Full Text] [Related]
18. [Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
Senova ZP; Lyskovtsev VV; Grigor'eva EK; Gorbunova VV; Kaverina NV
Kardiologiia; 1986 Aug; 26(8):24-8. PubMed ID: 3761845
[TBL] [Abstract][Full Text] [Related]
19. [The antifibrillatory properties of bonnecor].
Grigor'eva EK; Gorbunova VV
Farmakol Toksikol; 1990; 53(3):36-7. PubMed ID: 2387377
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
Gülker H; Thale J; Brisse B; Bender F
Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
